Takeda Pharmaceutical (TAK) Cash & Current Investments: 2018-2025

  • Takeda Pharmaceutical's Cash & Current Investments fell 16.69% to $2.7 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $17.6 billion, marking a year-over-year decrease of 27.96%. This contributed to the annual value of $2.7 billion for FY2025, which is 18.80% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Cash & Current Investments stood at $2.7 billion for Q1 2025, which was down 16.69% from $3.2 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's Cash & Current Investments' 5-year high stood at $9.5 billion during Q1 2021, with a 5-year trough of $2.7 billion in Q1 2025.
  • Over the past 3 years, Takeda Pharmaceutical's median Cash & Current Investments value was $3.2 billion (recorded in 2024), while the average stood at $3.3 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Cash & Current Investments surged by 57.86% in 2021 and then slumped by 44.40% in 2023.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Cash & Current Investments stood at $9.5 billion in 2021, then dropped by 20.53% to $7.5 billion in 2022, then slumped by 44.40% to $4.2 billion in 2023, then declined by 23.77% to $3.2 billion in 2024, then fell by 16.69% to $2.7 billion in 2025.
  • Its Cash & Current Investments stands at $2.7 billion for Q1 2025, versus $3.2 billion for Q1 2024 and $4.2 billion for Q1 2023.